Influential opinions and insights on companies

Our equity analysts ask the right questions, dig deeper for answers and find details others miss. Our research division covers key Canadian healthcare companies to understand how they operate, recognize their relative strengths and weaknesses, and determine the impact of clinical and commercial developments and competitive events.

Specialized equity research that gets attention

Our analysts make influential buy, sell and hold recommendations in healthcare and biotechnology, gather industry knowledge, and provide insightful market intelligence to help guide our investor clients.

Charting what’s new in biotech: Bloom Burton’s Top Ideas; Healthcare Sector Review/Preview

Our Top Ideas; Healthcare Sector Review/Preview report, published annually, is essential reading for institutional investors to track historical sector performance and glean insight for the upcoming year, including milestones that could impact share performance.

Distribution of healthcare research

Bloom Burton’s research products are disseminated simultaneously to all our customers who are authorised to receive them. Request to be added to Bloom Burton’s equity research distribution list. Email Brian Bloom at

Research Coverage

Advanz Pharma Corp. (TSX:ADVZ) (formerly Concordia International Corp.)

Aralez Pharmaceuticals Canada Inc. (TSX: ARZ, NASDAQ:ARLZ)

Aurinia Pharmaceuticals Inc. (TSX:AUP, NASDAQ:AUPH)

BELLUS Health Inc. (TSX:BLU)

BioSyent Inc. (TSXV:RX)

CannTrust Holdings Inc. (TSX:TRST)

Clementia Pharmaceuticals Inc. (NASDAQ: CMTA)

Correvio Pharma Corp. (TSX:CORV, NASDAQ:CORV) (formerly Cardiome Pharma Corporation)

Cipher Pharmaceuticals Inc. (TSX:CPH)

CRH Medical Corporation (TSX:CRH, NYSE-MKT:CRHM)


Greenbrook TMS Inc. (TSX:GTMS)

Hamilton Thorne Ltd. (TSX-V:HTL)

HLS Therapeutics Inc. (TSX-V:HLS)

Knight Therapeutics Inc. (TSX:GUD)

Novelion Therapeutics (NASDAQ: NVLN)

Nuvo Pharmaceuticals (TSX:NRI)

ProMetic Life Sciences (TSX:PLI)

Trillium Therapeutics Inc. (TSX:TR, NASDAQ:TRIL)

Xenon Pharmaceuticals (NASDAQ:XENE)

Latest News

Newsletter Sign Up

Recent Tweets